[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This patient presents with decompensated heart failure in the setting of severe aortic stenosis, but has developed dynamic left ventricular outflow tract (LVOT) obstruction with systolic anterior motion (SAM) of the mitral valve and severe mitral regurgitation. This represents a hypertrophic obstructive cardiomyopathy (HOCM)-like physiology.\n\nThe key findings are:\n- Hyperdynamic LV with near-cavity obliteration\n- SAM of the mitral valve\n- High LVOT gradient (120 mmHg)\n- Hypotension\n- New mitral regurgitation\n\nIn this scenario, the immediate goal is to reduce the LVOT obstruction by:\n1. Increasing preload\n2. Increasing afterload\n3. Decreasing contractility\n4. Decreasing heart rate\n\nPhenylephrine (option A) is an alpha-1 agonist that increases systemic vascular resistance (afterload) without increasing heart rate or contractility. This would help expand the LV cavity, reduce SAM, and improve forward flow.\n\nBeta-blockers like esmolol (option B) can help by reducing contractility and heart rate, but may worsen hypotension acutely.\n\nNitroglycerin (option C) would reduce preload and afterload, worsening LVOT obstruction.\n\nFurosemide (option D) would reduce preload, worsening LVOT obstruction.\n\nMilrinone (option E) is an inotrope that would increase contractility and worsen LVOT obstruction.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most likely cause of refractory pulmonary hypertension in this neonate, I'll analyze the key clinical features:\n\n- 3-day-old full-term neonate with progressive respiratory distress\n- Minimal response to surfactant therapy\n- Severe pulmonary hypertension with suprasystemic pressures\n- Right-to-left shunting\n- Chest X-ray showing diffuse granular opacities with air bronchograms\n\nAnalyzing each option:\n\nA. Congenital alveolar capillary dysplasia - This is a rare, lethal developmental disorder characterized by defective formation of alveolar capillaries. It presents with severe, refractory pulmonary hypertension that is unresponsive to conventional therapies including surfactant. The clinical picture described matches this condition perfectly.\n\nB. Meconium aspiration syndrome - While this can cause pulmonary hypertension, it typically presents immediately after birth and would show patchy infiltrates rather than diffuse granular opacities on X-ray.\n\nC. Transient tachypnea of the newborn - This is a self-limiting condition that typically improves within 24-72 hours and doesn't cause severe pulmonary hypertension.\n\nD. Group B streptococcal pneumonia - While this can cause respiratory distress and pulmonary hypertension, it would typically respond at least partially to surfactant and would show more inflammatory features.\n\nE. Idiopathic respiratory distress syndrome - This condition is more common in premature infants and typically responds well to surfactant therapy.\n\nThe clinical picture of severe, refractory pulmonary hypertension with minimal response to surfactant is most consistent with alveolar capillary dysplasia.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "I need to determine the most appropriate immediate intervention for this patient who has developed signs of cardiac tamponade after trauma.\n\nThe patient initially presented with hypotension and a positive FAST exam showing fluid in the hepatorenal recess, suggesting intra-abdominal bleeding. Despite initial resuscitation, her condition has deteriorated with the development of a large pericardial effusion with diastolic right ventricular collapse on ultrasound, which are classic findings of cardiac tamponade.\n\nCardiac tamponade is a life-threatening condition requiring immediate decompression of the pericardial space to restore cardiac output.\n\nLet me evaluate each option:\n\nA. Emergency department thoracotomy - While this would allow access to the heart, it's more invasive than necessary for an initial approach to tamponade.\n\nB. Pericardiocentesis via subxiphoid approach - This is the fastest, least invasive method to relieve cardiac tamponade by draining the pericardial fluid.\n\nC. Left anterolateral tube thoracostomy - This would drain a hemothorax but would not address the pericardial effusion.\n\nD. Right tube thoracostomy - Similarly, this would not address the pericardial effusion.\n\nE. Laparotomy with aortic cross-clamping - This would address intra-abdominal bleeding but not the immediate threat of cardiac tamponade.\n\nGiven the clear evidence of cardiac tamponade (large pericardial effusion with diastolic right ventricular collapse), the most appropriate immediate intervention is pericardiocentesis.\n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "I'll analyze this case step by step:\n\nThe patient presents with:\n- Symmetric inflammatory polyarthritis affecting wrists, MCPs, and knees\n- Morning stiffness >1 hour\n- Facial rash\n- Positive labs: ANA 1:1280 (speckled), anti-Smith positive, anti-RNP positive\n- Proteinuria\n- Normal complement levels\n\nThese findings are consistent with Systemic Lupus Erythematosus (SLE).\n\nTwo weeks after starting hydroxychloroquine, she develops:\n- Acute dyspnea\n- Pleuritic chest pain\n- Hypoxia\n- CT findings: bilateral ground-glass opacities and pleural effusions (without PE)\n\nLet's evaluate each option:\n\nA. Lupus pneumonitis - This is an acute inflammatory condition of the lungs in SLE patients, presenting with dyspnea, pleuritic chest pain, hypoxia, and ground-glass opacities on imaging. This matches our patient's presentation.\n\nB. Drug reaction to hydroxychloroquine - While possible, hydroxychloroquine rarely causes acute pulmonary toxicity, especially after only two weeks of therapy.\n\nC. Acute pulmonary hemorrhage from vasculitis - Possible in SLE, but typically presents with hemoptysis, which isn't mentioned.\n\nD. Pulmonary hypertension due to SLE - Develops gradually, not acutely, and wouldn't explain the ground-glass opacities.\n\nE. Opportunistic infection - Unlikely after only two weeks of hydroxychloroquine, which is not strongly immunosuppressive.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To address this case of a 55-year-old man with MEN1 syndrome presenting with hypoglycemia and elevated insulin/C-peptide levels, I need to determine the best next management step when standard imaging has failed to localize a pancreatic lesion.\n\nThis patient has biochemical evidence of endogenous hyperinsulinism (low glucose with inappropriately elevated insulin and C-peptide), strongly suggesting an insulinoma in the context of MEN1. However, conventional imaging (EUS and Ga-68 DOTATATE PET/CT) has not identified a lesion.\n\nIn this scenario:\n- Empiric distal or total pancreatectomy would be overly aggressive without knowing the exact location of the lesion\n- Diazoxide or somatostatin analogs are medical therapies that could help manage symptoms but don't address the need for localization\n- Selective arterial calcium stimulation with hepatic venous sampling (SACST) is a functional localization technique that can help identify the region of the pancreas containing insulin-secreting tumor cells when conventional imaging fails\n\nSACST is particularly valuable in MEN1 patients where multiple small insulinomas may be present but not visible on imaging. This test can guide more targeted surgical intervention rather than proceeding with empiric extensive pancreatic resection.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely genetic mutation responsible for this clinical picture, I'll analyze the key features presented:\n\n1. Short stature with growth falling below 1st percentile\n2. History of congenital hypothyroidism (already treated, with normal TSH/T4)\n3. Delayed bone age by 3 years\n4. Distinctive physical features: prominent forehead, depressed nasal bridge, small hands with brachydactyly\n\nLooking at the options:\n\nA. SHOX gene mutations cause Léri-Weill dyschondrosteosis or short stature in Turner syndrome, but don't typically cause hypothyroidism or the specific facial features described.\n\nB. GH1 gene mutations cause isolated growth hormone deficiency, but wouldn't explain the hypothyroidism or the specific physical features.\n\nC. GNAS1 gene mutations cause Albright hereditary osteodystrophy (AHO)/pseudohypoparathyroidism, which presents with short stature, brachydactyly, round face, and often hypothyroidism due to hormone resistance. This matches the clinical picture described.\n\nD. PROP1 gene mutations cause combined pituitary hormone deficiency, which could explain hypothyroidism and growth issues, but not the specific skeletal features described.\n\nE. FGFR3 gene mutations cause achondroplasia, which has disproportionate short stature but typically normal intelligence and no association with hypothyroidism.\n\nThe patient's presentation with hypothyroidism, short stature, and especially the brachydactyly and facial features is most consistent with Albright hereditary osteodystrophy.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most likely mechanism of acute severe mitral regurgitation following TAVI, I'll analyze the clinical scenario and each potential mechanism.\n\nThe patient has:\n- Severe calcific aortic stenosis treated with TAVI\n- Immediate post-deployment findings of well-seated valve with mild paravalvular leak\n- New severe MR with eccentric anteriorly directed jet\n- Hyperdynamic LV function\n\nAnalyzing each option:\n\nA. Iatrogenic injury - While possible, direct injury to the mitral apparatus during TAVI is uncommon with balloon-expandable valves and would typically present with a different jet pattern.\n\nB. Dynamic LVOT obstruction with SAM - The hyperdynamic LV, sudden afterload reduction from treating AS, and eccentric anteriorly directed jet are all consistent with SAM of the mitral valve causing functional MR. This is a recognized complication after sudden afterload reduction.\n\nC. Unmasking pre-existing MR - While afterload reduction can unmask MR, the sudden onset and severity suggest a new mechanical issue rather than pre-existing pathology.\n\nD. Valve prosthesis impingement - This can occur but typically causes restricted leaflet motion rather than the eccentric anteriorly directed jet described.\n\nE. Acute papillary muscle dysfunction - There's no mention of coronary occlusion, and this would typically cause posteriorly directed MR.\n\nThe hyperdynamic LV with sudden afterload reduction most strongly supports dynamic LVOT obstruction with SAM.\n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most urgent diagnostic test for this infant, I need to analyze the clinical presentation and laboratory findings.\n\nThe infant presents with:\n- Poor feeding, lethargy, vomiting\n- Hemodynamic instability (tachycardia, hypotension, mottled appearance, delayed capillary refill)\n- Hyponatremia (Na 125 mEq/L)\n- Severe hyperkalemia (K 8.9 mEq/L)\n- Metabolic acidosis (CO2 14 mEq/L)\n- Hypoglycemia (glucose 48 mg/dL)\n- Low cortisol (2 mcg/dL)\n\nThis constellation of findings strongly suggests adrenal insufficiency, specifically congenital adrenal hyperplasia (CAH), most commonly due to 21-hydroxylase deficiency. The most characteristic laboratory finding in 21-hydroxylase deficiency is elevated 17-hydroxyprogesterone.\n\nThe clinical picture represents an adrenal crisis requiring immediate intervention. While all the tests listed could be helpful, the most urgent diagnostic test to confirm the underlying etiology would be serum 17-hydroxyprogesterone level, which is the hallmark diagnostic test for the most common form of CAH.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "To determine the best answer, I need to identify which echocardiographic finding most strongly indicates cardiac tamponade physiology requiring intervention in this patient with systemic sclerosis and a pericardial effusion.\n\nLet me analyze each option:\n\nA. Right atrial diastolic collapse - This is an early sign of tamponade and indicates increased pericardial pressure exceeding right atrial pressure during diastole.\n\nB. Respiratory variation in mitral inflow velocity >25% - This represents significant respiratory variation in left ventricular filling, a sign of hemodynamic compromise in tamponade.\n\nC. Inferior vena cava plethora with <50% collapse on sniff - This indicates elevated right atrial pressure but is less specific for tamponade.\n\nD. Swinging heart motion - This is a non-specific finding in large effusions and doesn't necessarily indicate hemodynamic compromise.\n\nE. Left atrial compression during systole - This is a late and very specific sign of cardiac tamponade, indicating that pericardial pressure exceeds left atrial pressure, which requires significantly elevated pericardial pressures.\n\nAmong these findings, left atrial compression during systole is the most specific and concerning sign of advanced tamponade physiology requiring intervention.\n\nThe answer is (E)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Based on the case presentation, this 16-year-old girl experienced sudden cardiac arrest during exercise with ECG findings showing ST-segment elevation and echocardiogram demonstrating apical hypokinesis with basal hypercontractility. These findings are consistent with stress cardiomyopathy (Takotsubo) or possibly a channelopathy such as Long QT syndrome or catecholaminergic polymorphic ventricular tachycardia (CPVT).\n\nGiven her young age, cardiac arrest during exercise, and the pattern of wall motion abnormalities, the most critical next step would be to prevent another potentially fatal arrhythmic event. While all options have merit in different scenarios:\n\n- Coronary angiography would be indicated for suspected acute coronary syndrome, but is less likely in a 16-year-old\n- Beta-blockers would be helpful for many arrhythmic conditions but aren't the most immediate intervention\n- IVIG would be used for inflammatory cardiomyopathies\n- Calcium gluconate would not be indicated in this scenario\n\nThe wearable cardioverter-defibrillator provides immediate protection against recurrent life-threatening arrhythmias while further evaluation is conducted to determine the underlying cause.\n\nThe answer is (C)"}]